A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.

ABSTRACT:

SUBMITTER: Paul S 

PROVIDER: S-EPMC11770971 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature